These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10756541)

  • 1. Design of polymeric prodrugs of PGE1 for cell-specific hepatic targeting.
    Hashida M; Akamatsu K; Nishikawa M; Yamashita F; Yoshikawa H; Takakura Y
    Pharmazie; 2000 Mar; 55(3):202-5. PubMed ID: 10756541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of polymeric prodrugs of prostaglandin E(1) having galactose residue for hepatocyte targeting.
    Hashida M; Akamatsu K; Nishikawa M; Yamashita F; Takakura Y
    J Control Release; 1999 Nov; 62(1-2):253-62. PubMed ID: 10518658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a hepatocyte-specific prostaglandin E(1) polymeric prodrug and its potential for preventing carbon tetrachloride-induced fulminant hepatitis in mice.
    Akamatsu K; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1242-9. PubMed ID: 10454500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological activity of a novel water-soluble hepatocyte-specific polymeric prodrug of prostaglandin E(1) using lactosylated poly(L-glutamic hydrazide) as a carrier.
    Akamatsu K; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M
    Biochem Pharmacol; 2001 Dec; 62(11):1531-6. PubMed ID: 11728389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery.
    Hirabayashi H; Nishikawa M; Takakura Y; Hashida M
    Pharm Res; 1996 Jun; 13(6):880-4. PubMed ID: 8792426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of prostaglandin E1 to hepatocytes using galactosylated liposomes.
    Kawakami S; Munakata C; Fumoto S; Yamashita F; Hashida M
    J Drug Target; 2000; 8(3):137-42. PubMed ID: 10938523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cyclic AMP- and ATP-mediated stimulation of DNA synthesis following partial hepatectomy by prostaglandin-E1 in D-galactosamine injured liver].
    Shimura T; Miyazaki M; Koshikawa H; Takahashi O; Sugasawa H; Fujimoto S; Okui K
    Nihon Geka Gakkai Zasshi; 1985 Dec; 86(12):1618-24. PubMed ID: 3003557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
    Mistry NP; Desai JL; Thakkar HP
    J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition characteristics of glycosylated poly(amino acids) as liver cell-specific drug carrier.
    Akamatsu K; Imai M; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M
    J Drug Target; 1998; 6(3):229-39. PubMed ID: 9888309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro skin penetration and pharmacodynamic evaluation of prostaglandin E1 ethyl ester, a vasoactive prodrug of prostaglandin E1, formulated into alcoholic hydrogels.
    Park HS; Yang SW; Choi SU; Choi HG; Yong CS; Choi YW; Lee J
    Pharmazie; 2006 Nov; 61(11):933-7. PubMed ID: 17152986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbation of acute pancreatitis in the presence of chronic liver injury in rats, with special reference to therapeutic efficacy of prostaglandin E1.
    Takahashi H; Imamura M; Mikami Y; Yamauchi H
    Pancreas; 1999 Aug; 19(2):199-204. PubMed ID: 10438168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs.
    Kawakami S; Munakata C; Fumoto S; Yamashita F; Hashida M
    J Pharm Sci; 2001 Feb; 90(2):105-13. PubMed ID: 11169527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E1 incorporated in lipid microspheres (lipo PGE1).
    Otomo S; Mizushima Y; Aihara H; Yokoyama K; Watanabe M; Yanagawa A
    Drugs Exp Clin Res; 1985; 11(9):627-31. PubMed ID: 3880049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives.
    Yabe Y; Nishikawa M; Tamada A; Takakura Y; Hashida M
    J Pharmacol Exp Ther; 1999 May; 289(2):1176-84. PubMed ID: 10215702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of prostaglandin E1 on the expression of tissue inhibitor of metalloproteinase-1 in experimental liver fibrosis rats].
    Liu SJ; Shen SR; Wang XY; Tang WL; Wang F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):383-6. PubMed ID: 16859129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of leukocyte adherence and transendothelial migration in cultured human liver vascular endothelial cells by prostaglandin E1.
    Lou J; Bühler L; Deng S; Mentha G; Montesano R; Grau GE; Morel P
    Hepatology; 1998 Mar; 27(3):822-8. PubMed ID: 9500713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties.
    Nishikawa M; Takemura S; Takakura Y; Hashida M
    J Pharmacol Exp Ther; 1998 Oct; 287(1):408-15. PubMed ID: 9765363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver targeting of catalase by cationization for prevention of acute liver failure in mice.
    Ma SF; Nishikawa M; Katsumi H; Yamashita F; Hashida M
    J Control Release; 2006 Jan; 110(2):273-282. PubMed ID: 16316705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E1 cytoprotection against CCl4-induced necrosis in isolated rat liver cells.
    Mihas AA
    Res Commun Chem Pathol Pharmacol; 1992 Feb; 75(2):173-84. PubMed ID: 1570402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic stellate cell contraction is inhibited by lipo-prostaglandin E1 in vitro.
    Wang XE; Watanabe S; Oide H; Hirose M; Itatsu T; Osada T; Takazakura Y; Yokoi Y; Sato N
    J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S14-8. PubMed ID: 9792030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.